Mary Lucas Selected Research

RNA Polymerase III

4/2016

Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Lucas Research Topics

Disease

7	Systemic Scleroderma (Systemic Sclerosis) 04/2014 - 01/2003
3	Body Remains 01/2024 - 01/2022
3	Myositis (Idiopathic Inflammatory Myopathies) 04/2014 - 01/2004
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2012 - 11/2007
2	Bacterial Infections (Bacterial Infection) 04/2014 - 06/2010
2	Infections 10/2011 - 06/2010
1	Calculi (Calculus) 06/2022
1	Dental Calculus 06/2022
1	Dental Plaque 06/2022
1	Anemia 04/2016
1	Primary Immunodeficiency Diseases 11/2015
1	Common Variable Immunodeficiency 10/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2012
1	Neoplasms (Cancer) 10/2011
1	Mycoses (Diseases, Fungus) 06/2010
1	Bruton type agammaglobulinemia 06/2010
1	Bronchiectasis 06/2010
1	Breakthrough Infections 06/2010
1	Autoimmune Diseases (Autoimmune Disease) 05/2010
1	Fibrosis (Cirrhosis) 07/2009
1	Pulmonary Hypertension 11/2007
1	Lung Diseases (Lung Disease) 11/2007
1	Hypoxia (Hypoxemia) 11/2007
1	Joint Diseases (Joint Disease) 09/2007
1	Arthritis (Polyarthritis) 09/2007
1	Polymyositis 01/2004
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2004
1	Dermatomyositis (Dermatopolymyositis) 01/2004
1	Antisynthetase syndrome 01/2004

Drug/Important Bio-Agent (IBA)

6	AutoantibodiesIBA 04/2014 - 01/2004
4	IsotopesIBA 01/2024 - 01/2022
3	AntibodiesIBA 04/2016 - 07/2009
3	Immunoglobulins (Immunoglobulin)IBA 11/2015 - 06/2010
3	trioctyl phosphine oxide (TOPO)IBA 09/2012 - 08/2007
2	Immunoglobulin G (IgG)IBA 11/2015 - 06/2010
1	CarbonIBA 06/2022
1	SugarsIBA 06/2022
1	Biocompatible Materials (Biomaterials)IBA 06/2022
1	CarbohydratesIBA 06/2022
1	CarbonatesIBA 06/2022
1	Indicators and Reagents (Reagents)IBA 06/2022
1	MineralsIBA 06/2022
1	Durapatite (Hydroxylapatite)IBA 06/2022
1	CollagenIBA 01/2022
1	RNA Polymerase IIIIBA 04/2016
1	RNA (Ribonucleic Acid)IBA 10/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2011
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2010
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2007
1	EnzymesIBA 09/2007
1	ImmunosorbentsIBA 09/2007
1	Jo-1 antibodyIBA 09/2007
1	anti-scl-70 autoantibodiesIBA 08/2007
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2007
1	Antinuclear AntibodiesIBA 01/2007
1	Signal Recognition ParticleIBA 01/2004
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2004
1	anticentromere antibodyIBA 01/2003

Therapy/Procedure

2	Therapeutics 11/2015 - 10/2011
1	Antibiotic Prophylaxis 04/2014
1	Drug Therapy (Chemotherapy) 10/2011